Polyneuron

Swiss biotech start-up. We’re using our Antibody-Catch® technology to develop accurate treatments for rare autoimmune disorders.

[Rachel Hevey @DrRachelHevey]

Lab Technician in Molecular Biology position available.

Applications still open for 2 more weeks!

[Rachel Hevey @DrRachelHevey]

Applications for our postdoc position in glycochemistry are open for one more week - come join our team !! 🥳

#postdoc #glycotime #medchem

[Rachel Hevey @DrRachelHevey]

Available 2-yr postdoc in glycomimetics/polymers!

We are looking to fill a position at @UniBasel_en for spring 2021. Prior experience in glycochemistry preferred.

Retweets appreciated! 📢📢📢
#glycotime #gotglycans @ComGlyco

[Polyneuron @polyneuron]

Polyneuron CEO Ruben Herrendorff: ‘The excitement to build something that is hopefully of significance and lasting value is rewarding’ https://t.co/NSPsT1QvkS

[Swiss Business Hub USA @SBH_USA]

Great potential 📈 Basel-based company @polyneuron has secured 36.5 million #Swiss francs from #investors, including U.S. venture capital firm New Enterprise Associates @NEA! 👏

Find out more 👉 https://t.co/SUl8ydsZvh

#WhySwitzerland #Swisspharma #innovation #invest #SBHUSA

[APOPO @herorats]

Today one of our very own #HeroRATs - MAGAWA - makes history as the first rat to be awarded the #PDSAGoldMedal by @PDSA_HQ! So proud of you Magawa, keep up the good work! 🥰🏅🐭

Find out more and watch his story: https://t.co/C6EqyIBLeZ

[BaseLaunch @BaseLaunch]

🎉 Way to go @polyneuron having just announced an extension of Series A of CHF 14 million, bringing the total to CHF 36.5 million! Read the story and access the press release here: https://t.co/Eqo2puOutP
#financing #biotech

[Venture Kick @venturekick]

CHF 36.5 Million against autoimmune diseases: @Polyneuron from Basel extends Series A!

Congrats to biotech founder Ruben Herrendorff and his amazing team!

Read more: https://t.co/epuZRPgiHN

#VentureKick #Biotech #LifeScience #Switzerland

[Venturelab @venturelab_ch]

Only one week after the Startup Awards, TOP 100 scale-up startup @Polyneuron accelerates its pace, raising CHF 36.5 Million. Congratulations to Venture Leader Ruben & his fantastic team - way to go!!!

#VLeadersLifeSciences #TOP100SSU #10xTOP100 #SwissStartups #Biotech

[Polyneuron @polyneuron]

Startups from the Basel Area ranked among the best - Basel Area Business & Innovation https://t.co/nVxfFmcjXp

[Tracxn @Tracxn]

Congrats!! @ovivahealth, @nearprotocol, @bestmile, @agcutiss, @frontify, @polyneuron, @getavrios, @bluecodepayment have made to Soonicorn Club 2020: Top Tech Startups In Switzerland! https://t.co/JfT7WFMTBi

#Zurich #Zug #cloud #AI #AR #VR #Crypto #tech #startup

[Swiss Business Hub @SBH_Germany]

Ein Medikament der Basler @polyneuron hat von der amerik. Gesundheitsbehörde FDA den Status als #OrphanDrug für seltene Krankheiten erhalten. Das #Medikament namens PN-1007 wurde für die Behandlung der Autoimmunkrankheit Anti-MAG-Neuropathie entwickelt.
https://t.co/zkwTqYDMY4

[Basel Area Life Sciences Supercluster @BaselArea]

Die @BILANZ porträtiert 100 Senkrechtstarter: Die (Erfolg-)Reichsten unter 40 Jahren - Herzliche Gratulation an Ruben Herrendorff, Gründer von @polyneuron, ein @UniBasel Spin-off und @BaseLaunch Portfolio Firma https://t.co/670CU7AwfB

#AccelerateInBasel #LifeSciences #startup

[Polyneuron @polyneuron]

Hope for Rare Neuropathy By Targeting Specific Autoantibodies https://t.co/lL6RPyqXIu

[startupticker @startuptickerCH]

FDA approval paves the way for two Swiss startups @polyneuron @GtxMedical https://t.co/jTTCK1tVwi | The Swiss Startup News channel https://t.co/e2acMZA7un

[Halsin Partners @Halsin]

Client @Polyneuron has received approval in France, the Netherlands, and the UK to begin #clinicalstudy with PN-1007 in anti-MAG #neuropathy #drugdevelopment

https://t.co/9oOjooc9Pe

[Polyneuron @polyneuron]

#Polyneuron receives approval in France, the Netherlands, and the UK to begin #clinicalstudy with PN-1007 in anti-MAG #neuropathy

https://t.co/IbYag8bmXT

[startupticker @startuptickerCH]

Polyneuron submits clinical trial application for its lead product and appoints Debra Barker, M.D. as Chief Medical Officer https://t.co/jTTCK1tVwi | The Swiss Startup News channel https://t.co/OpyxkCm61J

[Polyneuron @polyneuron]

We are extremely pleased to welcome Debra Barker to #Polyneuron as our #chiefmedicalofficer.

[Dr Darshana Nadkarni @DarshanaN]

Historically, the therapeutic strategy to #autoimmune diseases has been a sledgehammer approach. However deeper understanding of underlying biology and novel ways of stratifying patients are creating new approaches . Panel @EBDgroup @polyneuron @VielaBio #BiotechShowcase